↓ Skip to main content

Dove Medical Press

Frequency, clinical features and differential response to therapy of concurrent ALK/EGFR alterations in Chinese lung cancer patients

Overview of attention for article published in Drug Design, Development and Therapy, May 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter
2 X users
reddit
1 Redditor

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
19 Mendeley
Title
Frequency, clinical features and differential response to therapy of concurrent ALK/EGFR alterations in Chinese lung cancer patients
Published in
Drug Design, Development and Therapy, May 2019
DOI 10.2147/dddt.s196189
Pubmed ID
Authors

Jixian Liu, Zhimin Mu, Li Liu, Kang Li, Richeng Jiang, Peng Chen, Qiang Zhou, Meiling Jin, Yuxiang Ma, Yuancai Xie, Jianxing Xiang, Bing Li, Yafeng Ma, Xinru Mao, Lu Zhang, Tengfei Zhang, Da Wu

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 19 100%

Demographic breakdown

Readers by professional status Count As %
Other 2 11%
Researcher 2 11%
Student > Bachelor 2 11%
Student > Master 2 11%
Student > Doctoral Student 1 5%
Other 1 5%
Unknown 9 47%
Readers by discipline Count As %
Agricultural and Biological Sciences 3 16%
Pharmacology, Toxicology and Pharmaceutical Science 2 11%
Medicine and Dentistry 2 11%
Nursing and Health Professions 1 5%
Unknown 11 58%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 December 2021.
All research outputs
#16,387,941
of 25,870,940 outputs
Outputs from Drug Design, Development and Therapy
#952
of 2,287 outputs
Outputs of similar age
#209,928
of 365,796 outputs
Outputs of similar age from Drug Design, Development and Therapy
#12
of 31 outputs
Altmetric has tracked 25,870,940 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,287 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.4. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 365,796 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.